Abstract:Background & aims: Short bowel syndrome (SBS) is the leading cause of chronic intestinal failure. The duration of parenteral support (PS) and the long-term micronutrient needs in children with SBS vary, based on their clinical and anatomical characteristics. Our study aimed to review the clinical course and identify high risk patient groups for prolonged PS and long-term micronutrient supplementation. Methods: A retrospective review was conducted on electronic medical records of children with SBS and chronic intestinal failure who were enrolled in the multidisciplinary intestinal rehabilitation program at Manchester Children's Hospital, UK. Children were included in the review if they required PN for more than 60 days out of 74 consecutive days and had at least 3 years of follow-up. Statistical analysis was performed using IBM SPSS Statistics 24.0. Results: 40 children with SBS achieved enteral autonomy (EA) and 14 remained dependent on PS after 36 months of follow up. Necrotizing enterocolitis was the most common cause for intestinal resection (38.9%) followed by gastroschisis (22.2%), malrotation with volvulus (20.4%), segmental volvulus (9.3%) and long segment Hirschsprung disease (1.9%). Those who achieved EA had significantly longer intestinal length 27.5% (15.0-39.3) than those who remained on PS 6.0% (1.5-12.5) (p < 0.001). Type I SBS was only found in the PS cohort. Median PN dependence was 10.82 months [IQR 5.73-20.78]. Congenital diagnosis was associated with longer PN dependence (21.0 ± 20.0) than acquired (8.7 ± 7.8 months), (p = 0.02). The need for micronutrient supplementation was assessed after the transition to EA; 87.5% children had at least one micronutrient depletion, most commonly Vitamin D (64.1%), followed by iron (48.7%), Vitamin B12 (34.2%), and vitamin E (28.6%). Iron deficiency and vitamin A depletion were correlated with longer PS after multivariate analysis (OR: 1.103, 1.006-1.210, p = 0.037 and OR: 1.048, 0.998-1.102, p = 0.062 respectively). Conclusion: In our cohort, small bowel length was the main predictor for EA. Children on longer PS, had more often a congenital cause of resection and were at risk for micronutrient deficiencies in EA.

Prognostic factor of patients with short bowel syndrome due to nonCrohn disease: A single institution observational study

Etiologies and treatments of chronic intestinal failure-short bowel syndrome (SBS) in Japanese adults: a real-world observational study

Severe Short-Bowel Syndrome after Total Small Bowel Resection

Short Bowel Syndrome: A Paradigm for Intestinal Adaptation to Nutrition?

The Ratio of Remaining to Expected Small Bowel Length Predicts Enteral Autonomy in Pediatric Patients with Short Bowel Syndrome

An overview of the current management of short-bowel syndrome in pediatric patients

Outcomes of Children With Short Bowel Syndrome: Experiences in a Multidisciplinary Intestinal Rehabilitation Unit Over Two Decades

Management of Short Bowel Syndrome (SBS) and Intestinal Failure

Parenteral Nutrition and Intestinal Failure

Intestinal failure and short bowel syndrome

Key issues in addressing the clinical and humanistic burden of short bowel syndrome in the US

Fecal microbiome and bile acid metabolome in adult short bowel syndrome

Intestinal Continuity Alleviates Pediatric Intestinal Failure-Associated Liver Disease

Experience on Enteral Nutrition in Short Bowel Syndrome

Surgical Treatment of Short Bowel Syndrome—The Past, the Present and the Future, a Descriptive Review of the Literature

Emerging treatments for short bowel syndrome in adult patients

Parenteral support and micronutrient deficiencies in children with short bowel syndrome: A comprehensive retrospective study

Risk Factors for Renal Impairment in Adult Patients With Short Bowel Syndrome

Impact of intestinal lengthening on the nutritional outcome for children with short bowel syndrome

Fecal Microbiota Signatures of Adult Patients with Different Types of Short Bowel Syndrome

Clinical analysis of 36 patients with short bowel syndrome and intestinal fistula